FDA Adverse Event
Malfunction
Summary report: N
HEMOCHRON JR SIGNATURE SYSTEM
MDR report key: 2057955
·
Received March 9, 2011
Report
- Report Number
- 2248721-2011-00032
- Event Type
- Malfunction
- Date Received
- March 9, 2011
- Report Date
- February 10, 2011
- Manufacturer
- INTERNATIONAL TECHNIDYNE CORP.
- Product Code
- JPA
- PMA / PMN Number
- K940401
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OR, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
Additional Manufacturer Narrative · 1
(B)(4). METHOD: MANUFACTURER/EVALUATION/INVESTIGATION CURRENTLY IN PROCESS. ACTUAL DEVICE INVOLVED IN COMPLAINT WAS EVALUATED. RESULT: CUSTOMER COMPLAINT COULD NOT BE CONFIRMED. CONCLUSION CODE: NO CONCLUSION CAN BE DRAWN. ITC HAS REQUESTED ALL DATA REQUIRED FOR FORM 3500A.
Description of Event or Problem · 1
PATIENT 1 OF 2. HEALTHCARE PROFESSIONAL REPORTS HEMOCHRON JR SIGNATURE SYSTEM DISCREPANCY SINCE SWITCHING CUVETTE LOT. PT/INR 9.2, LAB PT/INR 2.8. PATIENT TREATMENT WAS BASED ON THE LAB PT/INR. THE PATIENT'S THERAPEUTIC RANGE IS 2.0-3.0. PATIENT IS ON ANTICOAGULATION REGIMEN OF BOTH COUMADIN AND LOW MOLECULAR WEIGHT HEPARIN. ALL LIQUID QUALITY CONTROL TESTS HAVE BEEN ACCEPTABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | HEMOCHRON JR SIGNATURE SYSTEM | JPA | INTERNATIONAL TECHNIDYNE CORP. | HEM JR-CUVET FG | H0JPT081 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | LOVENOX| COUMADIN |